Inna Chervoneva, PhD

Contact Dr. Chervoneva

1015 Chestnut Street
Suite 520
Philadelphia, PA 19107

(215) 955-4083
(215) 503-3804 fax

Most Recent Peer-reviewed Publications

  1. Bimodal coupling of ripples and slower oscillations during sleep in patients with focal epilepsy
  2. Changes in cerebellar functional connectivity and autonomic regulation in cancer patients treated with the Neuro Emotional Technique for traumatic stress symptoms
  3. Neuro emotional technique effects on brain physiology in cancer patients with traumatic stress symptoms: preliminary findings
  4. Buprenorphine for the treatment of the neonatal abstinence syndrome
  5. Extensions of D-optimal minimal designs for symmetric mixture models
  6. Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas
  7. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma. Comparison with Institutional Controls
  8. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer
  9. How Do Intensity and Duration of Rehabilitation Services Affect Outcomes From Severe Traumatic Brain Injury? A Natural Experiment Comparing Health Care Delivery Systems in 2 Developed Nations
  10. Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms
  11. An in vivo reporter to quantitatively and temporally analyze the effects of CDK4/6 inhibitor-based therapies in melanoma
  12. RhoA inhibits neural differentiation in murine stem cells through multiple mechanisms
  13. Correlation of acute tubular injury in reperfusion biopsy with renal transplant outcomes
  14. Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers
  15. Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein
  16. Prevalence, Risk Factors, and Correlates of Anxiety at 1 Year after Moderate to Severe Traumatic Brain Injury
  17. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells
  18. Changes in the preferences of US physicians-in-training for medical interventions throughout medical education
  19. Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types
  20. Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells